跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,236 条关于
“Reviva Pharmaceuticals Holdings”
全部
11,236
临床试验
1,486
药物
1,796
机构
2,234
资讯
5,720
去年
Reviva Pharmaceuticals' Brilaroxazine Shows Positive Phase 3 Results for Schizophrenia Treatment
去年
Reviva to Present Long-Term Phase 3 Data for Brilaroxazine in Schizophrenia at SIRS Congress
10个月前
Reviva Secures European Patent for Brilaroxazine in Pulmonary Fibrosis Treatment
去年
Reviva Pharmaceuticals Reports Promising Preliminary OLE Data for Brilaroxazine
去年
Reviva Pharmaceuticals' Brilaroxazine Receives Buy Rating Following Positive Phase 3 Schizophrenia Data
去年
Shuttle Pharmaceuticals Announces $4.5 Million Public Offering to Advance Ropidoxuridine Clinical Trials
去年
Reviva Presents Positive Brilaroxazine Data on Speech Latency in Schizophrenia from Phase 3 RECOVER Trial
去年
MEDIPAL Holdings and JCR Pharmaceuticals Partner on Novel GM2 Gangliosidosis Therapy JR-479
去年
Reviva Presents Positive Speech Latency Data for Brilaroxazine in Schizophrenia from Phase 3 RECOVER Trial
去年
Reviva Pharma's Brilaroxazine Shows Positive Speech Latency Data in Phase 3 Schizophrenia Trial
第 1 页，共 572 页
上一页
下一页
